Showing results (21-30 of 389) with videos related to
Sort By:
Pageof 39
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
New antibody-drug conjugates (ADCs) in breast cancer-an overview of ADCs recently approved and in later stages of developmentKira-Lee Koster, Jens Huober, Markus JoergerExploration of Targeted Anti-Tumor Therapy|September 1, 2022
Liver venous deprivation for resection of advanced hilar cholangiocarcinoma-a case report and review of the literatureRadoslava Stoyanova, Helmut Kopf, Wolfgang Schima, et al.Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Advances in the study of cancer metastasis and calcium signaling as potential therapeutic targetsChaochu Cui, Yongxi Zhang, Gang Liu, et al.Exploration of Targeted Anti-Tumor Therapy|September 8, 2022
A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitorsVincenzo Raimondi, Nicolas Thomas Iannozzi, Jessica Burroughs-Garcìa, et al.Exploration of Targeted Anti-Tumor Therapy|September 8, 2022
miRNA therapeutics in precision oncology: a natural premium to nurtureChakresh Kumar Jain, Poornima Srivastava, Amit Kumar Pandey, et al.Exploration of Targeted Anti-Tumor Therapy|September 8, 2022
Applications and challenges of biomaterial mediated mRNA deliveryHuapan Fang, Qian ChenExploration of Targeted Anti-Tumor Therapy|September 8, 2022
Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challengesMariana Chantre-Justino, Gilda Alves, Lucas DelmonicoExploration of Targeted Anti-Tumor Therapy|January 6, 2025
Addressing the unmet need in NSCLC progression with advances in second-line therapeuticsKinsley Wang, Alexis Leyba, Robert HsuExploration of Targeted Anti-Tumor Therapy|March 24, 2025
A systematic review and meta-analysis of phase III randomized controlled trials to assess the risk of pneumonia, URTIs, and VTE in multiple myeloma patients treated with isatuximabDaniel Thomas Jones, Hazem Aboaid, Ramaditya Srinivasmurthy, et al.Exploration of Targeted Anti-Tumor Therapy|March 10, 2025
Genomic alterations in the WNT/β-catenin pathway and resistance of colorectal cancer cells to pathway-targeting therapiesIoannis A VoutsadakisPageof 39